Provided by Tiger Trade Technology Pte. Ltd.

SITC

34.520
-0.780-2.21%
Volume:4.68M
Turnover:163.06M
Market Cap:93.20B
PE:9.79
High:35.920
Open:35.580
Low:34.300
Close:35.300
52wk High:35.920
52wk Low:13.698
Shares:2.70B
HK Float Shares:2.70B
Volume Ratio:1.04
T/O Rate:0.17%
Dividend:2.35
Dividend Rate:6.81%
EPS(LYR):3.527
ROE:49.99%
ROA:21.56%
PB:4.80
PE(LYR):9.79
PS:3.49

Loading ...

HCW Biologics Presents Preclinical Data for TRBC-Based T-Cell Engager Program at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 07, 2025

Plus Therapeutics Highlights ReSPECT-LM Clinical Trial Results at 40th SITC Annual Meeting, Melanoma Research Foundation Brain Metastases Summit 4.0

GlobeNewswire
·
Nov 06, 2025

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire
·
Nov 04, 2025

Calidi Biotherapeutics Announces Investor Event to be Held on Friday, November 7th at the 2025 SITC Annual Meeting

GlobeNewswire
·
Nov 04, 2025

SITC International (01308) Announces October 2025 Monthly Return

Bulletin Express
·
Nov 04, 2025

SITC International Holdings Highlights Team Building and Green Development Initiatives

Reuters
·
Nov 03, 2025

Shipping Stocks Rally in Afternoon Trading as U.S.-China Trade Talks Yield Consensus; Institutions Expect Rapid Recovery in Maritime Trade

Stock News
·
Nov 03, 2025

Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

GlobeNewswire
·
Nov 03, 2025

Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting

GlobeNewswire
·
Oct 30, 2025

ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting

GlobeNewswire
·
Oct 30, 2025

Calidi Biotherapeutics Announces New Data to be Presented on its Therapeutic Lead, CLD-401, at the 2025 SITC Annual Meeting

GlobeNewswire
·
Oct 30, 2025

New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire
·
Oct 30, 2025

CICC Maintains Outperform Rating on SITC (01308) with Target Price of HK$36

Stock News
·
Oct 28, 2025

SITC International's Nine-month Revenue Jumps 17%

MT Newswires Live
·
Oct 24, 2025

SITC Reports Revenue of Approximately $2.459 Billion for the First Three Quarters, Up Approximately 16.6% Year-on-Year

Stock News
·
Oct 24, 2025

SITC International Holdings (1308) Reports 16.6% Revenue Growth and Updates on Share Scheme

Bulletin Express
·
Oct 24, 2025

SITC International Holdings 9-Month Revenue USD 2,108.5 Million

THOMSON REUTERS
·
Oct 24, 2025

IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting

GlobeNewswire
·
Oct 23, 2025

SITC International Opens New Logistics Office in Wuxi

Reuters
·
Oct 22, 2025

SITC Line Korea Highlights ESG Practices in 2025 Team-Building Event

Reuters
·
Oct 21, 2025